Intelligent Bio Solutions Inc. Makes Progress on FDA 510(k) Pathway with Successful Biocompatibility Study
Intelligent Bio Solutions Inc. (INBS), a medical technology company specializing in intelligent, rapid, and non-invasive testing solutions, recently achieved a significant milestone in its clinical study plan required for FDA 510(k) regulatory clearance. The company announced the successful completion of biocompatibility testing for its Intelligent Fingerprinting Drug Screening System. This development marks a pivotal phase in the Company’s efforts to secure regulatory clearance from the FDA.
The Intelligent Fingerprinting Drug Screening System is a cutting-edge technology that utilizes fingerprints to detect drug use. By utilizing this non-invasive method, the system provides fast and accurate results, making it an attractive alternative to traditional drug screening methods that often involve urine or blood tests.
Additionally, Intelligent Bio Solutions Inc. has been expanding its customer base in the United Kingdom. In the past three months, the company has secured two major customer accounts within the warehouse and logistics sector. These accounts encompass over 70 locations and employ more than 15,000 individuals. The adoption of INBS’ Intelligent Fingerprinting Drug Screening System by these accounts highlights the growing demand for the company’s innovative technology in various industries.
Moreover, Intelligent Bio Solutions Inc. has added a significant European transport and infrastructure solutions provider to its list of accounts. The company will be utilizing the Intelligent Fingerprinting Drug Screening System to monitor the fitness for duty of its employees in its United Kingdom operations. This addition further demonstrates the widespread adoption and recognition of INBS’ technology in improving workplace safety and efficiency.
Intelligent Bio Solutions Inc.’s recent success in completing the biocompatibility study for its Intelligent Fingerprinting Drug Screening System represents a major step towards securing FDA 510(k) regulatory clearance. As the company continues to expand its customer base, it demonstrates the growing demand for its non-invasive testing solutions across different sectors. By combining cutting-edge technology with accurate results, Intelligent Bio Solutions Inc. is positioned to make a significant impact in the field of drug screening.
Comments